Management of health-care workers exposed to blood and body fluids.
1. The risk of transmission of HIV from an infected patient to a percutaneously exposed HCW is about 1 in 200 to 300. 2. The exposure, the source patient and the HCW recipient must be assessed to determine the risk of HIV infection to the recipient. 3. Azidothymidine (AZT, zidovudine) is the only drug currently licensed by the FDA for the treatment of HIV infection.
Spechko
P L
PL
D001769:Blood; D001826:Body Fluids; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission; D006282:Health Personnel; D006509:Hepatitis B / Q000517:prevention & control / Q000635:transmission; D006526:Hepatitis C / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D016273:Occupational Exposure / Q000517:prevention & control*; D012307:Risk Factors; D016635:Universal Precautions; D015215:Zidovudine / Q000627:therapeutic use
D015215:Zidovudine